TUMOR TISSUE AND PATHOLOGY SHARED RESOURCE Project Summary The Tumor Tissue and Pathology Shared Resource (TTPSR) consists of three well-integrated laboratories, the Tumor Tissue Lab, the Human Pathology Lab, and the Comparative Pathology Lab, with one reception point for seamless operations. The Co-Directors of the Shared Resource are Edward Levine, M.D., and Barry DeYoung, M.D. The Managers of the three laboratories are Greg Kucera, Ph.D., (Tumor Tissue Lab), Shadi Qasem, M.D., (Human Pathology Lab), and David Caudell, D.V.M., Ph.D. (Comparative Pathology Lab). There are 6 technical staff members supporting the Shared Resource for a combined 4.16 FTE. The mission of the TTPSR is to facilitate translational cancer research by collecting and supplying high-quality, well-characterized human and animal tissues (neoplastic and normal); and providing pathology services to Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) members.
The Specific Aims of the TTPSR are to: 1) Collect and supply high-quality, well-characterized human and animal tissues (neoplastic and normal); 2) Provide scientific and pathological expertise related to tissue collection, processing, histological and immunological staining, and evaluation to support the development of clinical protocols, grant applications, and manuscripts; and 3) Provide pathology services for human and animal tissues for cancer investigations. Since the last competing renewal, the TTPSR has been enhanced by the addition of the Human and Comparative Pathology Laboratories, which provide much-needed resources to WFBCCC investigators. The Human Pathology Lab works closely with the Tumor Tissue Lab for quality control of samples and provides clinical pathology expertise to investigators. The Comparative Pathology Lab provides unique samples and pathology expertise for a variety of experimental animals ranging from rodents to non-human primates. These labs are equipped with state-of-the-art instrumentation that are overseen by certified pathologists and trained staff. The TTPSR maintains a web- based database for interaction of investigators with Shared Resource personnel and provides access to banked tissue inventories. At present, TTPSR has available over 44,180 tissue samples and collects tissues from approximately 1,100 patients per year. The Shared Resource provided services to 13 members during the most recent funding period: all of its users were WFBCCC members; 69% of whom have peer-reviewed funding. In the previous funding period (2006-2011), 261 samples were distributed, compared with 1001 samples for the current funding period (2011-2015), representing a 3.8-fold increase.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA012197-46
Application #
10092995
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-02-01
Project End
2022-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
46
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Xiao, Jiajie; Melvin, Ryan L; Salsbury Jr, Freddie R (2018) Probing light chain mutation effects on thrombin via molecular dynamics simulations and machine learning. J Biomol Struct Dyn :1-18
Mao, Chengqiong; Zhao, Yan; Li, Fang et al. (2018) P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors. J Control Release 286:289-300
Diaz-Garelli, Jose-Franck; Wells, Brian J; Yelton, Caleb et al. (2018) Biopsy Records Do Not Reduce Diagnosis Variability in Cancer Patient EHRs: Are We More Uncertain After Knowing? AMIA Jt Summits Transl Sci Proc 2017:72-80
Wang, Mingxuan; Chen, Haiqin; Ailati, Aisikaer et al. (2018) Substrate specificity and membrane topologies of the iron-containing ?3 and ?6 desaturases from Mortierella alpina. Appl Microbiol Biotechnol 102:211-223
Westcott, Marlena M; Clemens, Elene A; Holbrook, Beth C et al. (2018) The choice of linker for conjugating R848 to inactivated influenza virus determines the stimulatory capacity for innate immune cells. Vaccine 36:1174-1182
Ruiz, Jimmy; Miller, Antonius A; Tooze, Janet A et al. (2018) Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age. J Geriatr Oncol :
Levine, Edward A; Votanopoulos, Konstantinos I; Shen, Perry et al. (2018) A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors. J Am Coll Surg 226:434-443
Addington, Elizabeth L; Sohl, Stephanie J; Tooze, Janet A et al. (2018) Convenient and Live Movement (CALM) for women undergoing breast cancer treatment: Challenges and recommendations for internet-based yoga research. Complement Ther Med 37:77-79
Park, Sun H; Keller, Evan T; Shiozawa, Yusuke (2018) Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis. Calcif Tissue Int 102:152-162
Haas, Karen M; Johnson, Kristen L; Phipps, James P et al. (2018) CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens. J Immunol 200:1671-1681

Showing the most recent 10 out of 548 publications